Medeor® Matrix for Soft Tissue Repair

Medeor® Matrix

Medeor®  Matrix is a porcine dermis extracellular matrix (ECM) product developed for soft tissue repair applications that require robust strength and durability.  It is made from our proprietary OPTRIX™ process, which gently disinfects tissues, inactivates viruses and removes cells while preserving extracellular matrix components.

Medeor™ Matrix Features and Benefits:

Proven In-Vitro Biologic Activity

Kensey Nash invests in comprehensive analysis of our extracellular matrices to validate the gentle selectivity of the OPTRIX™ process, and to demonstrate the potential for increased biologic activity. Pre-clinical animal studies show:

• Greater retention of TGF-β and VEGF relative to incumbent commercial products ^{1, 2}
• Stimulated human dermal fibroblasts to produce more VEGF than incumbent commercial products ²

Potential Clinical Applications

At Kensey Nash we know that every clinical need poses unique challenges and requires specialized tools.  The versatility of our OPTRIX™ processing methods provides the opportunity to address a variety of soft tissue repair needs, such as:

References
1. Kensey Nash, Data on File
2. BioMaterials. 2010 Sep;31(27):6934-40.

Regulatory approvals are necessary before use of Medeor(TM) Matrix in human applications.
Medeor™ and Optrix™ are trademarks of Kensey Nash Corporation.